Cite
Clinical Outcomes of Patients With Recurrent Lung Cancer Reirradiated With Proton Therapy on the Proton Collaborative Group and University of Florida Proton Therapy Institute Prospective Registry Studies.
MLA
Badiyan, Shahed N., et al. “Clinical Outcomes of Patients With Recurrent Lung Cancer Reirradiated With Proton Therapy on the Proton Collaborative Group and University of Florida Proton Therapy Institute Prospective Registry Studies.” Practical Radiation Oncology, vol. 9, no. 4, July 2019, pp. 280–88. EBSCOhost, https://doi.org/10.1016/j.prro.2019.02.008.
APA
Badiyan, S. N., Rutenberg, M. S., Hoppe, B. S., Mohindra, P., Larson, G., Hartsell, W. F., Tsai, H., Zeng, J., Rengan, R., Glass, E., Katz, S., Vargas, C., Feigenberg, S. J., & Simone, C. B., 2nd. (2019). Clinical Outcomes of Patients With Recurrent Lung Cancer Reirradiated With Proton Therapy on the Proton Collaborative Group and University of Florida Proton Therapy Institute Prospective Registry Studies. Practical Radiation Oncology, 9(4), 280–288. https://doi.org/10.1016/j.prro.2019.02.008
Chicago
Badiyan, Shahed N, Michael S Rutenberg, Bradford S Hoppe, Pranshu Mohindra, Gary Larson, William F Hartsell, Henry Tsai, et al. 2019. “Clinical Outcomes of Patients With Recurrent Lung Cancer Reirradiated With Proton Therapy on the Proton Collaborative Group and University of Florida Proton Therapy Institute Prospective Registry Studies.” Practical Radiation Oncology 9 (4): 280–88. doi:10.1016/j.prro.2019.02.008.